About Us And Insulin Pump Therapy
Advanced Therapeutics (UK) Ltd (ATUK) is a UK-wide distributor of specialist medical devices based in Warwick in the West Midlands, with a particular focus on insulin pump therapy. Our hybrid closed loop system is one of the only systems cleared for use by children aged 1 and up and pregnant women.
Our mission is to source specialist medical devices that meet clinical needs, simplify insulin pump therapy and improve patient health and quality of life. We hope to introduce more of these devices to the UK so that those with Type 1 diabetes will benefit from them.
Providing Insulin Pump Therapy To More People Across The UK
We are the exclusive UK distributor for the SOOIL Development Co., Ltd range of insulin infusion pumps. The Dana i is SOOIL’s newest intuitive insulin pump. It is one of the most intelligent glucose management systems in the world, with improved BLE 5.0 Bluetooth and CamAPS® FX compatibility. Advanced Therapeutics have a history innovating in the insulin pump space, previously offering the Dana RS insulin pump, which in a world first allowed patients to remotely control the device from their own smartphone.
As well as supplying innovative devices, Advanced Therapeutics (UK) Ltd believes that providing first-class product education, training and support is an essential component of product provision. As a result of this, we offer initial and ongoing in-person training while working hard to maintain close relationships with both patients and healthcare professionals as this is an integral part of insulin pump therapy.
As an organisation, we pride ourselves on being approachable and we hope that all of our customers feel comfortable enough to ask us any questions they might have. If in doubt, we urge you to get in touch. We’re always here if you need quick, reliable and friendly service. We have a reputation amongst our existing customer base for great teamwork, advanced product knowledge and high levels of service, which are often proven to exceed those of our closest competitors.
An Overview Of Hybrid Closed Loop Therapy
Hybrid Closed Loop Therapy combines continuous glucose monitoring and real-time insulin delivery using advanced algorithms. This minimises manual intervention in insulin pump therapy, stabilises glucose levels and gives people with Type 1 diabetes more freedom.
A key benefit of Hybrid Closed Loop Therapy is its automation. Unlike conventional Type 1 diabetes management, which requires manual insulin calculation and administration, this system handles it with minimal intervention. What’s more, our Dana Diabecare i model has a 300-unit cartridge, which seamlessly accounts for considerable fluctuations in insulin delivery, such as in the later stages of pregnancy. All of this not only eases cognitive burden but also leads to more consistent and predictable glucose levels.
What Hybrid Closed Loop Therapy Could Mean For You
With an automated delivery system, an insulin pump becomes much more than just a insulin delivery device for individuals with Type 1 diabetes. It adapts seamlessly to the ebb and flow of daily life, effortlessly accommodating changes in diet, exercise and unforeseen circumstances. This adaptability grants a newfound sense of freedom and spontaneity, allowing individuals to pursue their passions without being encumbered by the demands of managing their Type 1 diabetes. The profound impact of this technology is felt not only in improved physical health but also in the restoration of confidence and independence for those who may have previously struggled.
Our Roots
Advanced Therapeutics was established with a mission to provide innovative and effective medical devices to the UK market. Our journey began with a commitment to meet real clinical needs, simplify therapy, and improve patient health and quality of life. Over the years, we have become known for our dedication to bringing cutting-edge insulin pump therapy to the UK, ensuring that people with Type 1 diabetes have access to the best possible care and technology.